ROMOSOZUMAB-AQQG for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 123 adverse event reports in the FDA FAERS database where ROMOSOZUMAB-AQQG was used for Off label use.
Most Reported Side Effects for ROMOSOZUMAB-AQQG
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fall | 646 | 5.7% | 35 | 360 |
| Fracture | 612 | 5.4% | 5 | 135 |
| Arthralgia | 517 | 4.6% | 0 | 41 |
| Injection site pain | 490 | 4.3% | 2 | 15 |
| Bone density abnormal | 454 | 4.0% | 0 | 1 |
| Off label use | 419 | 3.7% | 9 | 73 |
| Hospitalisation | 381 | 3.4% | 7 | 376 |
| Headache | 360 | 3.2% | 1 | 32 |
| Product storage error | 348 | 3.1% | 0 | 2 |
| Death | 263 | 2.3% | 258 | 19 |
| Spinal fracture | 256 | 2.3% | 2 | 52 |
| Pain in extremity | 255 | 2.2% | 0 | 27 |
| Injection site swelling | 254 | 2.2% | 0 | 8 |
| Injection site erythema | 247 | 2.2% | 0 | 8 |
| Pain | 235 | 2.1% | 3 | 32 |
Other Indications for ROMOSOZUMAB-AQQG
Product used for unknown indication (5,202)
Osteoporosis (4,398)
Osteoporosis postmenopausal (1,401)
Osteoporotic fracture (68)
Spinal fracture (50)
Senile osteoporosis (42)
Osteoporosis prophylaxis (40)
Osteopenia (33)
Fracture (26)
Compression fracture (24)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)